deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT02968784

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer

Focal ExAblate™ MR-Guided Focused Ultrasound (MRgFUS) Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer (OC-IRPC): Evaluation of Safety and Effectiveness

Sponsor: InSightec

Conditions Prostate Cancer
Interventions ExAblate MRgFUS
Updated 15 times since 2017 Last updated: May 5, 2023 Started: Jun 30, 2016 Primary completion: Feb 2, 2023 Completion: Feb 2, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor Decision

Other terminated trials from InSightec

See all terminations from InSightec

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

Listed as NCT02968784, this NA trial focuses on Prostate Cancer and remains terminated or withdrawn. Sponsored by InSightec, it has been updated 15 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshot~Sep 2017 – ~Mar 2018 · 6 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Jun 2019 · 7 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Aug 2020 · 11 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2022 · 20 months · monthly snapshot~Sep 2022 – ~Jun 2023 · 9 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jun 2023 — Jul 2024 [monthly]

    Terminated NA

    Status: Unknown Status → Terminated

  4. Sep 2022 — Jun 2023 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Jan 2021 — Sep 2022 [monthly]

    Recruiting NA

▶ Show 10 earlier versions

  1. Aug 2020 — Jan 2021 [monthly]

    Recruiting NA

  2. Sep 2019 — Aug 2020 [monthly]

    Recruiting NA

  3. Jun 2019 — Sep 2019 [monthly]

    Recruiting NA

  4. Nov 2018 — Jun 2019 [monthly]

    Recruiting NA

  5. Sep 2018 — Nov 2018 [monthly]

    Recruiting NA

  6. Jul 2018 — Sep 2018 [monthly]

    Recruiting NA

  7. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  8. Mar 2018 — Jun 2018 [monthly]

    Recruiting NA

  9. Sep 2017 — Mar 2018 [monthly]

    Recruiting NA

    Phase: PHASE2_PHASE3 → NA

  10. Jan 2017 — Sep 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • InSightec
Data source: InSightec

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations